'Bubble Boy' Disease Has a Cure, but Drug Companies Won't Provide It

Jakob, who was born with a rare illness, is 2 years old. But what's keeping him isolated from the world isn't his disease-- it's the marketplace.

Related Keywords

Hollywood ,California ,United States ,Stanford University ,Milan ,Lombardia ,Italy ,United Kingdom ,Texas ,British ,Matthew Porteus ,Donald Kohn ,Alessandro Aiuti ,Paola Andrea Fern ,Manny Lichtman ,John Travolta ,Ceos Andrea ,Maria Grazia Roncarolo ,David Vetter ,Emma Walmsley ,Jakob Kamil Guziak ,Peter Marks ,Ethan Perlstein ,Francesca Pasinelli ,Soto Abdul Rahim ,Jennifer Doudna ,Jude Children Research Hospital ,Division Of Rare Diseases Research Innovation ,National Institutes Of Health ,Drug Administration ,Telethon Foundation ,Novartis ,Big Pharma ,Texas Children ,Big Pharmas ,Orchard Therapeutics ,Mustang Bio ,Jude Children ,Research Hospital ,Great Abandonment ,Nobel Prize Winning ,Biologics Evaluation ,Rare Diseases Research Innovation ,National Institutes ,Drug Makers ,Disease ,Gene Therapy ,Bone Marrow Transplant ,Healthcare ,Discourse ,Drug Industry ,Drug Costs ,Drug Trial ,Bi Prime ,I Photo ,Creative Freelancers ,Andrew Dunn ,